12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok
12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok
12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
AutoHCT:<br />
1. linie terapi hos yngre ( 3 måneder efter transplantation). Om dette gælder <strong>for</strong><br />
patienten i 2. eller 3. remission er individuelt og afhængig af tidligere regimer.<br />
Referencer:<br />
AutoHCT:<br />
Andersen NS, Pedersen L, Elonen E et al. Primary treatment with autologous stem cell transplantation in mantle<br />
cell lymphoma: outcome related to remission pretransplant. Eur J Haematol 71:73-80, 2003<br />
Andersen NS, Pedersen LB, Laurell A, et al: Preemptive treatment with rituximab of molecular relapse after<br />
autologous stem cell transplantation in mantle cell lymphoma. J Clin Oncol 2009 epub ahead of press<br />
Dreyling M, Lenz G, Hoster E, Van Hoof A, Gisselbrecht C, Schmits R, Metzner B, Truemper L, Reiser M,<br />
Steinhauer H, Boiron JM, Boogaerts MA, Aldaoud A, Silingardi V, Kluin-Nelemans HC, Has<strong>for</strong>d J, Parwaresch R,<br />
Unterhalt M, Hiddemann W. Early consolidation by myeloablative radiochemotherapy followed by autologous<br />
stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell<br />
lymphoma: results of a prospective randomized trial of the European MCL Network. Blood. 2005 Apr<br />
1;105(7):2677-84.<br />
Dreyling M, Hoster E, Hermine O. European MCL Network: An Update on Current First Line Trials. Blood 110,<br />
2007 (Abstract 388)<br />
Gianni AM, Magni M, Martelli M, Di Nicola M, Carlo-Stella C, Pilotti S, Rambaldi A, Cortelazzo S, Patti C, Parvis<br />
G, Benedetti F, Capria S, Corradini P, Tarella C, Barbui T. Long-term remission in mantle cell lymphoma<br />
72
Change language